ZA942729B - Modified protein and peptide pharmaceuticals. - Google Patents

Modified protein and peptide pharmaceuticals.

Info

Publication number
ZA942729B
ZA942729B ZA942729A ZA942729A ZA942729B ZA 942729 B ZA942729 B ZA 942729B ZA 942729 A ZA942729 A ZA 942729A ZA 942729 A ZA942729 A ZA 942729A ZA 942729 B ZA942729 B ZA 942729B
Authority
ZA
South Africa
Prior art keywords
amino acid
ctp units
partial
complete
modified protein
Prior art date
Application number
ZA942729A
Other languages
English (en)
Inventor
Irving Boime
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of ZA942729B publication Critical patent/ZA942729B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA942729A 1993-04-20 1994-04-20 Modified protein and peptide pharmaceuticals. ZA942729B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4986993A 1993-04-20 1993-04-20

Publications (1)

Publication Number Publication Date
ZA942729B true ZA942729B (en) 1995-01-09

Family

ID=21962168

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA942729A ZA942729B (en) 1993-04-20 1994-04-20 Modified protein and peptide pharmaceuticals.

Country Status (14)

Country Link
EP (1) EP0695307B1 (pt)
JP (2) JP4156024B2 (pt)
AT (1) ATE187740T1 (pt)
AU (1) AU687053B2 (pt)
CA (1) CA2160800C (pt)
DE (1) DE69422169D1 (pt)
ES (1) ES2141229T3 (pt)
FI (1) FI954978A (pt)
GR (1) GR3032775T3 (pt)
NO (1) NO954188L (pt)
NZ (1) NZ265529A (pt)
PT (1) PT695307E (pt)
WO (1) WO1994024148A1 (pt)
ZA (1) ZA942729B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6319504B1 (en) * 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US7994278B1 (en) * 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
JP2001333772A (ja) 2000-04-25 2001-12-04 Washington Univ 可変性の活性を有する単鎖稔性ホルモン
EP1342730B1 (en) * 2000-12-11 2006-03-15 Cheil Jedang Corporation Fusion protein having the enhanced in vivo activity of erythropoietin
US6987172B2 (en) 2001-03-05 2006-01-17 Washington University In St. Louis Multifunctional single chain glycoprotein hormones comprising three or more β subunits
KR100467751B1 (ko) * 2001-12-03 2005-01-24 씨제이 주식회사 생체내 에리스로포이에틴 활성이 증진된 융합단백질
US9458444B2 (en) 2006-02-03 2016-10-04 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US8946155B2 (en) 2006-02-03 2015-02-03 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US8304386B2 (en) 2006-02-03 2012-11-06 Prolor Biotech, Inc. Long-acting growth hormone and methods of producing same
US8048848B2 (en) 2006-02-03 2011-11-01 Prolor Biotech Ltd. Long-acting interferons and derivatives thereof and methods thereof
US9249407B2 (en) 2006-02-03 2016-02-02 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US20150038413A1 (en) 2006-02-03 2015-02-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US8048849B2 (en) 2006-02-03 2011-11-01 Modigene, Inc. Long-acting polypeptides and methods of producing same
US8450269B2 (en) 2006-02-03 2013-05-28 Prolor Biotech Ltd. Long-acting growth hormone and methods of producing same
US7553941B2 (en) * 2006-02-03 2009-06-30 Modigene Inc Long-acting polypeptides and methods of producing same
US10221228B2 (en) 2006-02-03 2019-03-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US20140113860A1 (en) 2006-02-03 2014-04-24 Prolor Biotech Ltd. Long-acting polypeptides and methods of producing and administering same
US8476234B2 (en) 2006-02-03 2013-07-02 Prolor Biotech Inc. Long-acting coagulation factors and methods of producing same
US10351615B2 (en) 2006-02-03 2019-07-16 Opko Biologics Ltd. Methods of treatment with long-acting growth hormone
US9663778B2 (en) 2009-07-09 2017-05-30 OPKO Biologies Ltd. Long-acting coagulation factors and methods of producing same
CN104487082A (zh) 2012-04-19 2015-04-01 奥普科生物制品有限公司 长效胃泌酸调节素变体及其生产方法
BR122020018510B1 (pt) 2012-11-20 2023-03-14 Opko Biologics Ltd Método para aumentar incrementalmente o tamanho hidrodinâmico de um fator de coagulação ativado viia
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
US20150158926A1 (en) 2013-10-21 2015-06-11 Opko Biologics, Ltd. Long-acting polypeptides and methods of producing and administering same
CN107438623B (zh) * 2014-12-10 2023-07-14 Opko生物科学有限公司 长效的ctp修饰的生长激素多肽的制备方法
WO2016203482A2 (en) 2015-06-19 2016-12-22 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
HUE064463T2 (hu) 2016-07-11 2024-03-28 Opko Biologics Ltd Hosszantartó hatású VII. koagulációs faktor és az elõállítására vonatkozó eljárások

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654324A (en) * 1981-08-27 1987-03-31 Eli Lilly And Company Human proinsulin pharmaceutical formulations
US4959455A (en) * 1986-07-14 1990-09-25 Genetics Institute, Inc. Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
AU648020B2 (en) * 1989-02-21 1994-04-14 Washington University Modified forms of reproductive hormones
US6225449B1 (en) * 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
JPH04156024A (ja) * 1990-10-19 1992-05-28 Fujitsu Ltd サブレート交換方式

Also Published As

Publication number Publication date
NO954188D0 (no) 1995-10-19
FI954978A (fi) 1995-11-15
JP4156024B2 (ja) 2008-09-24
DE69422169D1 (de) 2000-01-20
WO1994024148A1 (en) 1994-10-27
NO954188L (no) 1995-12-19
EP0695307A1 (en) 1996-02-07
GR3032775T3 (en) 2000-06-30
EP0695307B1 (en) 1999-12-15
ATE187740T1 (de) 2000-01-15
EP0695307A4 (en) 1996-08-21
NZ265529A (en) 1998-01-26
ES2141229T3 (es) 2000-03-16
CA2160800C (en) 2010-06-01
CA2160800A1 (en) 1994-10-27
AU6633194A (en) 1994-11-08
FI954978A0 (fi) 1995-10-18
AU687053B2 (en) 1998-02-19
JPH08509218A (ja) 1996-10-01
PT695307E (pt) 2000-05-31
JP2008133295A (ja) 2008-06-12

Similar Documents

Publication Publication Date Title
GR3032775T3 (en) Modified protein and peptide pharmaceuticals
EP0607297A4 (en) Hormone analogs with multiple ctp extensions.
ES2163444T3 (es) Composiciones y metodos para la administracion oral de farmacos.
NO952744D0 (no) Cytokinbegrensende midler
DE69839812D1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
ATE368053T1 (de) Antimikrobielle peptide
ATE257859T1 (de) Humanes, rekombinantes interferon-beta mit verbesserter löslichkeit
DE69520475T2 (de) Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen
NO940299L (no) Peptid med organbeskyttende aktivitet
CA2071757A1 (en) Implant compositions containing a biologically active protein, peptide or polypeptide
ATE374246T1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
DE69121489D1 (de) In vitro-Behandlung von Fusionsproteinen
EP0723016A3 (en) Leukocyte activation factor
EP0272894A3 (en) Recombinant human lymphotoxin
TH18599EX (th) ยาที่เป็นโปรตีนและเพทไทด์ดัดแปลง
TH18599A (th) ยาที่เป็นโปรตีนและเพทไทด์ดัดแปลง
NL1000332C1 (nl) Graduele chemische modificatie van biologisch actieve peptiden en eiwitten.
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.